Letter to India’s Prime Minister: Grant Compulsory License for Bedaquiline and Delaminid

57, Tejaswinagar, Dharwad 580002. 0836-2461722
(Registered, independent NGO campaigning for Rational Drug Therapy and Policies)

Date 9th March 2018


The Prime Minister, New Delhi. narendramodi1234@gmail.com


Subject;- Granting of CL for Bedaquiline and Delaminid

We the undersigned learn from media report that two important drugs (Bedaquiline and Delaminid manufactured by Janssen of the USA and Otsuka of Japan) needed to treat Drug Resistance Tuberculosis (DR TB) are not available to Indian patients. Both the drug companies are ready to donate the medicines but it well known from previous experiences that such “donations” are only an excuse for the drug companies to tighten the grip over market and thus keep the drug price high. This will only keep the medicines away from the reach of the needy. Unfortunately the drug manufacturing companies are not even ready for voluntary licensing.

This leaves with only one option for India and that is granting of Compulsory Licensing (CL). According to a study published in Bulletin World Health Organization 2018 “found that countries made extensive use of TRIPS flexibilities between 2001 and 2016. This was previously unreported. The most frequently used measures were compulsory licensing, public non-commercial use licensing and the least-developed countries pharmaceutical transition measure, which together accounted for 79.5% (140/176) of instances. To date, the most comprehensive, published database lists 34 potential compulsory licences in 26 countries”.

This particular study establishes the fact that CL has been used by countries all over the world and so India has every right to use it under TRIPS flexibilities. It has also been a matter of concern that when the Indian generic drug company NATCO was granted CL, it subsequently faced several hurdles all created by MNC. But that should not deter Indian government from granting of CL

India needs to take bold steps so that the last person in our country is taken care and towards this granting of CL for two much needed Resistance TB medicines will be an important step.

Hoping to hear from you positively.

Yours truly

Dr Gopal Dabade (9448862270), Dr SL Pawar (9449354415),
Mr S R Hiremath (9448145930), Dr SC Bangalore (9482235427)

Copy to:- 1) Mr Anant Kumar, Minister Chemicals & Fertilizers, ananth@ananth.org
2) Mr JP Nadda, Minister for Health & Family Welfare, hfwminister@gov.in

This entry was posted in Compulsory Licensing, Drug prices, TRIPS flexibilities, Tuberculosis (TB), Uncategorized. Bookmark the permalink.

1 Response to Letter to India’s Prime Minister: Grant Compulsory License for Bedaquiline and Delaminid

  1. Pingback: Patient-Groups Worldwide Press India to Issue Compulsory Licenses for TB Drugs - Thewire

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s